Recent News for DOVA - Dova Pharmaceuticals, Inc.

Date Title
Aug 16 Analysis: Positioning to Benefit within Amtech, NL Industries, Dova Pharmaceuticals, Sientra, Dorian LPG, and Assembly Biosciences — Research Highlights Growth, Revenue, and Consolidated Results
Aug 15 Dova Pharma chief walks the walk with nearly $500K stock purchase
Aug 11 Dova Pharmaceuticals (DOVA) CEO Alex Sapir on Q2 2018 Results - Earnings Call Transcript
Aug 10 Some highs, lows as RTP biotech companies report earnings
Aug 9 Dova Pharmaceuticals: 2Q Earnings Snapshot
Aug 9 Dova Pharmaceuticals misses by $0.07, beats on revenue
Aug 9 Dova Pharmaceuticals Reports Second Quarter 2018 Operating and Financial Results
Aug 9 The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings
Jul 30 Dove Pharma file for $300M mixed shelf offering
Jul 26 Dova Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 9, 2018
Jul 9 This Biotech Finally Got A Drug Approved — But Its Battle Isn't Over
Jul 9 Midday Gainers / Losers (07/09/2018)
Jul 9 Healthcare - Top 5 Gainers / Losers as of 11:00 AM (07/09/2018)
Jul 9 Mid-Morning Market Update: Markets Open Higher; Helen of Troy Beats Q1 Expectations
Jun 25 Nancy J. Wysenski Joins Dova Pharmaceuticals’ Board of Directors
Jun 8 Another insider buy at Dova Pharma; shares up 3.3%
Jun 6 Dova Pharma up another 8% as insiders buy
Jun 4 Dova Pharmaceuticals Announces Publication of Pivotal Phase 3 Data and Upcoming Congress Presentations for DOPTELET® (avatrombopag)
May 31 Dova Pharmaceuticals Announces Availability of DOPTELET® in the United States
May 29 Dova Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference
May 25 Dova reveals expansion plans, days after landing FDA approval
May 25 Market Trends Toward New Normal in inTest, Westamerica, Simmons First National, Dova Pharmaceuticals, ScanSource, and Horizon Bancorp (IN) — Emerging Consolidated Expectations, Analyst Ratings
May 22 Dova Pharmaceuticals (DOVA) Doptelet FDA Approval Conference Call - Slideshow
May 22 Today’s Research Reports on Stocks to Watch: Dova Pharmaceuticals and Nabriva Therapeutics
May 22 Dova Pharmaceuticals Tumbles On FDA Approval, Golden Opportunity Emerges
Back to the Main DOVA Page...